Clinical Trial Update: Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing XELOX to oxaliplatin plus 5-FU as first-line therapy in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Oxaliplatin+5-FU CI (oxaliplatin plus continuous infusion 5-fluorouracil)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED